Molecular 'switch' that fuels cancer progression discovered

Researchers from the University of Cape Town's (UCT) Scientific Computing Research Unit (SCRU) have uncovered a critical molecular "switch" that drives the formation of cancer-associated antigens. The study, published in ...

A new era of personalized care for patients with meningioma

A comprehensive new review led by Mayo Clinic is helping shape how clinicians diagnose and treat meningioma, the most common primary brain tumor, with a focus on personalized, patient-centered care and the latest advances ...

page 18 from 40